The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.Hebang Bio established a mining engineering company in Leshan, Sichuan. The enterprise search APP shows that Leshan Hebang Mining Engineering Co., Ltd. was established recently, with Fei Wang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: mineral resources reserve evaluation service; Mineral resources reserve estimation and report preparation services; Geological disaster management services, etc. Enterprise investigation shows that the company is wholly owned by Hebang Bio.The full implementation of the personal pension system may bring more medium and long-term funds, and the allocation value of the Southern Shanghai and Shenzhen 300ETF(159925) has attracted much attention. On December 12, the Southern Shanghai and Shenzhen 300ETF(159925) closed up 1.07%, with a turnover of 92.5438 million yuan. The constituent stocks were all red, with Contemporary Amperex Technology Co., Limited rising by 2.47%, Kweichow Moutai rising by 1.97% and Wuliangye rising by 1.62%. China Merchants Bank and China Ping An followed suit. In the news, since December 15th, the personal pension system has been extended to the whole country, and the first batch of 85 index funds have been included in the product range, which has attracted attention, including 12 Shanghai and Shenzhen 300 index funds and 300ETF(159925) in South China. According to industry insiders, since the personal pension fund system came into being, both personal pension funds and sales organizations have steadily expanded. The increase of fund products and the continuous addition of new sales organizations will bring more medium and long-term funds to the capital market, and the Southern CSI 300ETF(159925) will benefit in the medium and long term.
Huaxin Securities: China Unicom's operating income grew steadily and maintained its "buy" rating. Huaxin Securities Research Report pointed out that since the beginning of this year, China Unicom (600050.SH) has seen steady growth in operating income, rapid improvement in profitability, steady expansion of user scale and continuous consolidation of network foundation, laying a more solid foundation for high-quality development of enterprises. Communication and digital intelligence services are driven by two wheels, injecting vitality into the company's performance. Looking forward to the whole year, the company will adhere to the general tone of steady progress, promote the network to be new, technology to be new and service to be new, strive to achieve the performance goal of steady growth of operating income and double-digit growth of profits throughout the year, take greater steps in high-quality development, and accelerate the construction of a world-class science and technology service enterprise with global competitiveness. With the gradual expansion of user scale and the drive of digital transformation, the company will benefit from the continuous improvement of revenue and profit and maintain the "buy" investment rating.Ai Kelan: Liu Yi, the actual controller, intends to transfer 5% of the company's shares by agreement, with a total transaction price of 82.44 million yuan. Liu Yi, the controlling shareholder and actual controller, signed a share transfer agreement with Guangdong Nanchuan Private Equity Fund Management Co., Ltd., and Liu Yi intends to transfer 4 million unrestricted shares of the company (accounting for 5% of the company's total share capital) to Nanchuan Private Equity through agreement transfer. The transfer price is 20.61 yuan per share, and the total transaction price is 82.44 million yuan. This change in equity will not lead to changes in the controlling shareholder or actual controller of the company, and will not lead to changes in the control rights of listed companies.Shanghai Science and Technology Commission: Increase financial support for projects in the fields of scientific instruments, scientific research reagents and technical standards in the Action Plan for Scientific and Technological Innovation, and Shanghai Science and Technology Commission issued the Action Plan for Promoting the Innovative Development of Scientific Instruments and Scientific Research Reagents in Shanghai (2025-2027). The plan points out that financial input should be increased. We will increase support for projects in the fields of scientific instruments, scientific research reagents and technical standards in the Action Plan for Science and Technology Innovation, support technology research and development, product development and standard development, select and fund high-end scientific instruments and scientific research reagent products, and support the construction of technical test and verification platforms, application scenarios and user experience centers. 16. Strengthen financial support. Establish and improve the industrial venture capital mechanism, encourage and guide market capital to participate in industrial development. Give play to the role of the parent fund of the three leading industries and the future industrial fund, encourage social capital investment, support debt financing, mergers and acquisitions, and promote enterprises to become bigger and stronger.
The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)The full implementation of the personal pension system may bring more medium and long-term funds, and the allocation value of the Southern Shanghai and Shenzhen 300ETF(159925) has attracted much attention. On December 12, the Southern Shanghai and Shenzhen 300ETF(159925) closed up 1.07%, with a turnover of 92.5438 million yuan. The constituent stocks were all red, with Contemporary Amperex Technology Co., Limited rising by 2.47%, Kweichow Moutai rising by 1.97% and Wuliangye rising by 1.62%. China Merchants Bank and China Ping An followed suit. In the news, since December 15th, the personal pension system has been extended to the whole country, and the first batch of 85 index funds have been included in the product range, which has attracted attention, including 12 Shanghai and Shenzhen 300 index funds and 300ETF(159925) in South China. According to industry insiders, since the personal pension fund system came into being, both personal pension funds and sales organizations have steadily expanded. The increase of fund products and the continuous addition of new sales organizations will bring more medium and long-term funds to the capital market, and the Southern CSI 300ETF(159925) will benefit in the medium and long term.Schlegel, Governor of the Swiss National Bank: We still have ammunition left over in terms of interest rates. Inflationary pressure has dropped in the medium term. Our main tool is the policy interest rate, through which we can influence the economy and exchange rate.